{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:32:55Z","timestamp":1760297575987},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Surgical Oncology"],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1007\/bf02303782","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T22:13:01Z","timestamp":1139955181000},"page":"253-260","source":"Crossref","is-referenced-by-count":14,"title":["Molecular oncogene markers and their significance in cutaneous malignant melanoma"],"prefix":"10.1007","volume":"5","author":[{"given":"Manoussos M.","family":"Konstadoulakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Vezeridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Hatziyianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine P.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirby I.","family":"Bland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold J.","family":"Wanebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02303782_CR1","first-page":"349","volume":"138","author":"SR Cajal","year":"1991","unstructured":"Cajal SR, Suster S, Halaban R, et al. Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu and E1a oncogenes.Am J Path 1991;138:349\u201358.","journal-title":"Am J Path"},{"key":"BF02303782_CR2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00001622-199403000-00012","volume":"6","author":"M Runger","year":"1994","unstructured":"Runger M, Klein CE, Becter JC, Brocker EB. The role of genetic instability, adhesion, cell motility and immune escape mechanisms in melanoma progression.Curr Opin Oncol 1994;6:188\u201396.","journal-title":"Curr Opin Oncol"},{"key":"BF02303782_CR3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.ge.22.120188.003215","volume":"22","author":"S Lindquist","year":"1988","unstructured":"Lindquist S, Craig EA. The heat-shock proteins.Annu Rev Genet 1988;22:631\u201377.","journal-title":"Annu Rev Genet"},{"key":"BF02303782_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.ge.20.120186.002045","volume":"20","author":"MD Cole","year":"1986","unstructured":"Cole MD. The myc oncogene: its role in transformation and differentiation.Annu Rev Genet 1986;20:361\u201384.","journal-title":"Annu Rev Genet"},{"key":"BF02303782_CR5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1097-0142(1971)28:5<1255::AID-CNCR2820280524>3.0.CO;2-A","volume":"28","author":"SH Bennet","year":"1971","unstructured":"Bennet SH, Futrel JW, Roth J, et al. Prognostic significance of histologic host response in cancer of the larynx or hypolarynx.Cancer 1971;28:1255\u20136.","journal-title":"Cancer"},{"key":"BF02303782_CR6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/1097-0142(197112)28:6<1453::AID-CNCR2820280618>3.0.CO;2-P","volume":"28","author":"JW Berg","year":"1971","unstructured":"Berg JW. Morphological evidence for immune response to breast cancer. A histologic review.Cancer 1971;28:1453\u20136.","journal-title":"Cancer"},{"key":"BF02303782_CR7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00000658-198212001-00011","volume":"1196","author":"CM Balch","year":"1982","unstructured":"Balch CM, Soong SJ et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (Stage I) melanoma treated in Alabama, USA and New South Wales, Australia.Ann Surg 1982;1196:677.","journal-title":"Ann Surg"},{"key":"BF02303782_CR8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-198808000-00002","volume":"12","author":"WH McCarthy","year":"1988","unstructured":"McCarthy WH, Shaw HM, Milton GW. Efficacy of elective lymph nodes of patients with pathological stage I malignant melanoma.Am J Surg Pathol 1988;12:612\u201318.","journal-title":"Am J Surg Pathol"},{"key":"BF02303782_CR9","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2","volume":"49","author":"U Veronesi","year":"1982","unstructured":"Veronesi U, Adamaus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities.Cancer 1982;49:2420\u201330.","journal-title":"Cancer"},{"key":"BF02303782_CR10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-6196(12)62768-2","volume":"61","author":"FH Sim","year":"1986","unstructured":"Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study.Mayo Clin Proc 1986;61:697\u2013705.","journal-title":"Mayo Clin Proc"},{"key":"BF02303782_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","volume":"224","author":"CM Balch","year":"1996","unstructured":"Balch CM, Soong S-J, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1- to 4-mm thick melanomas for patients 60 years of age and younger.Ann Surg 1996;224:255\u201366.","journal-title":"Ann Surg"},{"key":"BF02303782_CR12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-198808000-00002","volume":"12","author":"AJ Cochran","year":"1988","unstructured":"Cochran AJ, Wen D-R, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma.Am J Surg Pathol 1988;12:612\u201318.","journal-title":"Am J Surg Pathol"},{"key":"BF02303782_CR13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wonj JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392.","journal-title":"Arch Surg"},{"key":"BF02303782_CR14","first-page":"757","volume":"12","author":"E Mattei","year":"1992","unstructured":"Mattei E, Damas D, Mileo AM, Delpino A, Ferrini V. Stress response, survival and enhancement of heat sensitivity in a human melanoma cell line treated with L-Conavanine.Anticancer Res 1992;12:757\u201362.","journal-title":"Anticancer Res"},{"key":"BF02303782_CR15","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/0006-2952(92)90338-J","volume":"44","author":"EL Steels","year":"1992","unstructured":"Steels EL, Watson K, Parsons PB. Relationship between thermo tolerance, oxidative stress responses and induction of stress proteins in human tumor cell lines.Biochem Pharma 1992;44:2123\u20139.","journal-title":"Biochem Pharma"},{"key":"BF02303782_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00008390-199212000-00011","volume":"2","author":"A Delpino","year":"1992","unstructured":"Delpino A, Sponsanti P, Mattei E, Mileo AM, Vismara D, Ferrini U. Identification of a 66kD heat shock protein (HSP) induced in M-14 human melanoma cells by severe hyperthermia treatment.Melanoma Res 1992;2:369\u201375.","journal-title":"Melanoma Res"},{"key":"BF02303782_CR17","first-page":"5249","volume":"47","author":"SW Carper","year":"1987","unstructured":"Carper SW, Duffy JT, Gerner EW. Heat shock proteins in thermotolerance and other cellular processes.Cancer Res 1987;47:5249\u201355.","journal-title":"Cancer Res"},{"key":"BF02303782_CR18","first-page":"146","volume":"3","author":"FK Storm","year":"1993","unstructured":"Storm FK, Mahvi DM, Gilchrist KW. HSP-27 is not expressed and has no prognostic significance in rectal adenocarcinoma.Reg Cancer Treat 1993;3:146\u20138.","journal-title":"Reg Cancer Treat"},{"key":"BF02303782_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02303701","volume":"2","author":"FK Storm","year":"1985","unstructured":"Storm FK, Gilchrist KW, Warner TF et al. Distribution of HSP-27 and her-2\/neu in in-situ and invasive ductal breast carcinomas.Ann Surg Oncol 1985;2:43\u20138.","journal-title":"Ann Surg Oncol"},{"key":"BF02303782_CR20","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1128\/MCB.6.5.1796","volume":"6","author":"G Symonds","year":"1986","unstructured":"Symonds G, Klempmauer KH, Snyder M, Moscovici G, Moscovici C, Bishop JM. Coordinate registration of myelomonocytic phenotype by v-myb and v-myc.Mol Cell Biol 1986;6:1796\u20131802.","journal-title":"Mol Cell Biol"},{"key":"BF02303782_CR21","first-page":"338","volume":"9","author":"JP Johnson","year":"1989","unstructured":"Johnson JP, Lehman JM, Stade BG, et al. Functional aspects of three molecules associated with metastatic development in human malignant melanoma.Invasion Metastasis 1989;9:338\u201350.","journal-title":"Invasion Metastasis"},{"key":"BF02303782_CR22","first-page":"233","volume":"37","author":"J Bauer","year":"1990","unstructured":"Bauer J, Sokol L, Stribma J, et al. Amplification of N-myc oncogene in human melanoma cells.Neoplasma 1990;37:233\u20138.","journal-title":"Neoplasma"},{"key":"BF02303782_CR23","first-page":"507","volume":"71","author":"AK Bhan","year":"1983","unstructured":"Bhan AK, Desmarais CV. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrates in human breast cancerJ Natl Cancer Inst 1983;71:507\u201313.","journal-title":"J Natl Cancer Inst"},{"key":"BF02303782_CR24","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/1097-0142(19820401)49:7<1456::AID-CNCR2820490724>3.0.CO;2-#","volume":"49","author":"IM Shimokawara","year":"1982","unstructured":"Shimokawara IM, Yamanaka N, et al. Identification of lymphocyte subpopulations in human breast cancer tissue and its significance.Cancer 1982;49:1456\u201364.","journal-title":"Cancer"},{"key":"BF02303782_CR25","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.4049\/jimmunol.129.6.2808","volume":"129","author":"DJ Ruiter","year":"1982","unstructured":"Ruiter DJ, Bran AK, Harist TJ, et al. Major histocompatibility antigens and mononuclear inflammatory infiltrates in benign nevomelanocytic proliferation and malignant melanoma.J Immunol 1982;129:2815.","journal-title":"J Immunol"},{"key":"BF02303782_CR26","first-page":"903","volume":"13","author":"E Thorsby","year":"1981","unstructured":"Thorsby E, Bergholtz B, Berlest, et al. Involvement of HLA in T-cell immune responses.Transplant Proc 1981;13:903\u20138.","journal-title":"Transplant Proc"},{"key":"BF02303782_CR27","first-page":"562","volume":"100","author":"CM Balch","year":"1986","unstructured":"Balch CM. Immune responses to tumor antigens and their clinical applications.Surgery 1986;100:562\u201371.","journal-title":"Surgery"},{"key":"BF02303782_CR28","first-page":"20","volume":"102","author":"AK Bhan","year":"1981","unstructured":"Bhan AK, Perry LL, Cantor H, et al. The role of T cell sets in the rejection of methylcholanthrene induced sarcoma (S 1509a) in syngeneic mice.Am J Pathol 1981;102:20\u20137.","journal-title":"Am J Pathol"},{"key":"BF02303782_CR29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2559.1992.tb01011.x","volume":"20","author":"PS Colloby","year":"1992","unstructured":"Colloby PS, West KP, Fletcher A. Is poor prognosis really related to HLA-Dr expression by malignant melanoma cells?Histopathology 1992;20:411\u20136.","journal-title":"Histopathology"},{"key":"BF02303782_CR30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01669428","volume":"3","author":"M Munzarova","year":"1989","unstructured":"Munzarova M, Zemanova D, Rejthar A, et al. HLA-DR antigen expression on melanoma metastases and the course of the disease.Cancer Immunol Immunother 1989;3:185\u20139.","journal-title":"Cancer Immunol Immunother"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02303782.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02303782\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02303782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T13:38:36Z","timestamp":1683380316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02303782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["BF02303782"],"URL":"https:\/\/doi.org\/10.1007\/bf02303782","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}